The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Covidien Prevails in Patent Action against Applied Medical Resources

Wednesday, April 04, 2012

Covidien Prevails in Patent Action against Applied Medical Resources07:30 EDT Wednesday, April 04, 2012 MANSFIELD, Mass. (Business Wire) -- Covidien (NYSE: COV), a leading global provider of healthcare products, announced that it has prevailed against Applied Medical Resources Corp. in a patent action before the U.S. District Court, Central District of California. In granting Covidien's motion of summary judgment, the District Court ruled that Covidien's trocar products do not infringe Applied Medical's patent. In May 2011, Applied Medical sued Covidien in connection with Covidien's sale of certain trocar products. “We are pleased that the Court recognized that Covidien's trocar products are differentiated from our competitors,” said Scott Herring, Vice President, Endomechanical and Energy Division, Covidien Surgical Solutions. ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business. CovidienMarta Newhart, 303-476-7383Vice PresidentCommunications & Public Affairsmarta.newhart@covidien.comorBruce Farmer, 508-452-4372Vice PresidentPublic Relationsbruce.farmer@covidien.comorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor Relationscole.lannum@covidien.comorTodd Carpenter, 508-452-4363DirectorInvestor Relationstodd.carpenter@covidien.com